Coronavirus Disease 2019 Vaccination for Cancer Patients: Risk or Benefit? [PDF]
Laporte BEP +4 more
europepmc +1 more source
Variantes genéticas recurrentes y priorización de variantes de significado clínico desconocido asociadas al síndrome de cáncer de mama y ovario hereditario en familias de la Región de Murcia. [PDF]
Rosado-Jiménez L +12 more
europepmc +1 more source
Past, present, and future of screening for cervical cancer in Brazil: lessons learned? [PDF]
Migowski A.
europepmc +1 more source
Cervical Mesonephric Adenocarcinoma: A Case Report of a Rare Gynecological Tumor from Embryological Remains of the Female Genital Tract. [PDF]
Reis-de-Carvalho C +4 more
europepmc +1 more source
Factors related to Nursing workload in the Oncology assistance provided to hospitalized women. [PDF]
Balaminut T +3 more
europepmc +1 more source
Use of individualized starting dose and niraparib hematologic adverse event management costs in ovarian cancer. [PDF]
Graybill WS +23 more
europepmc +1 more source
3D bioprinted breast tumor-stroma models for pre-clinical drug testing. [PDF]
González-Callejo P +6 more
europepmc +1 more source
Unmet Supportive Care Needs in Cancer Survivors in Spain: A Multicentre Cross-Sectional Study on Prevalence and Sociodemographic and Disease-Related Risk Factors. [PDF]
Andreu Y +4 more
europepmc +1 more source
Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients. [PDF]
Pascual J +22 more
europepmc +1 more source
Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial. [PDF]
Monk BJ +29 more
europepmc +1 more source

